¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"z"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
18
ÄÚµå
¿µ¹®
ÇѱÛ
Z51.1
Chemotherapy session for neoplasm
½Å»ý¹°¿¡ ´ëÇÑ ÈÇпä¹ý ±â°£
Z93.3
Colostomy status
°áÀåÁ¶·ç¼ú(°áÀå·ç¼³Ä¡¼ú) »óÅÂ
Z20
Contact with and exposure to communicable diseases
Àü¿°¼º Áúȯ¿¡ Á¢ÃË ¹× ³ëÃâ
Z20.6
Contact with and exposure to human immunodeficiency virus[HIV]
ÀÎü¸é¿ª°áÇ̹ÙÀÌ·¯½º[HIV]¿¡ Á¢ÃË ¹× ³ëÃâ
Z20.2
Contact with and exposure to infections with a predominantly sexual mode of transmission
ÁÖ·Î ¼ºÇàÀ§·Î ÀüÆÄµÇ´Â °¨¿°¿¡ Á¢ÃË ¹× ³ëÃâ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½